Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review

Date: December 13, 2016
Pages: 38
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A34065A0D30EN
Leaflet:

Download PDF Leaflet

Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review
Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amarillo Biosciences Inc (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Its product portfolio includes a dietary supplement product, Maxisal to treat dryness of mouth. The company utilizes injectable interferon, an FDA-approved technology to develop drugs for the treatment of neoplastic, viral and autoimmune diseases. It has development partners in China and Taiwan, Japan, Malaysia, India and Nepal. ABI is headquartered in Amarillo, Texas, the US.

Amarillo Biosciences Inc Key Recent Developments

Oct 06, 2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon
May 18, 2015: Amarillo Biosciences Summarizes New Plan of Operation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Amarillo Biosciences Inc - Key Facts
    Amarillo Biosciences Inc - Key Employees
    Amarillo Biosciences Inc - Key Employee Biographies
    Amarillo Biosciences Inc - Major Products and Services
    Amarillo Biosciences Inc - Pharmaceutical Pipeline Products Data
    Amarillo Biosciences Inc, Pipeline Products by Therapy Area
    Amarillo Biosciences Inc, Pipeline Products by Development Phase
    Amarillo Biosciences Inc - History
    Amarillo Biosciences Inc - Company Statement
    Amarillo Biosciences Inc - Locations And Subsidiaries
    Head Office

    SECTION 2 – COMPANY ANALYSIS

    Amarillo Biosciences Inc - Business Description
    Amarillo Biosciences Inc - Corporate Strategy
    Amarillo Biosciences Inc - SWOT Analysis
    SWOT Analysis - Overview
    Amarillo Biosciences Inc - Strengths
    Amarillo Biosciences Inc - Weaknesses
    Amarillo Biosciences Inc - Opportunities
    Amarillo Biosciences Inc - Threats
    Amarillo Biosciences Inc - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Amarillo Biosciences Inc, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Oct 06, 2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon
    May 18, 2015: Amarillo Biosciences Summarizes New Plan of Operation

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Amarillo Biosciences Inc, Key Facts
    Amarillo Biosciences Inc, Key Employees
    Amarillo Biosciences Inc, Key Employee Biographies
    Amarillo Biosciences Inc, Major Products and Services
    Amarillo Biosciences Inc, Number of Pipeline Products by Therapy Area
    Amarillo Biosciences Inc, Number of Pipeline Products by Development Stage
    Amarillo Biosciences Inc, Pipeline Products By Therapy Area and Development Phase
    Amarillo Biosciences Inc, History
    Amarillo Biosciences Inc, Key Competitors
    Amarillo Biosciences Inc, Ratios based on current share price
    Amarillo Biosciences Inc, Annual Ratios
    Amarillo Biosciences Inc (Cont...1), Annual Ratios
    Amarillo Biosciences Inc, Interim Ratios
    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Amarillo Biosciences Inc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Amarillo Biosciences Inc, Pipeline Products by Therapy Area
    Amarillo Biosciences Inc, Pipeline Products by Development Phase
    Amarillo Biosciences Inc, Performance Chart (2011 - 2015)
    Amarillo Biosciences Inc, Ratio Charts
    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: